Researchers investigate the need for prioritizing COVID-19 booster vaccination.
A rational design approach to RNA targeting could replace large-scale screening – Pharmaceutical Technology
Maria Duca speaking at the ELRIG Drug Discovery conference in London, UK. Credit: Frankie Fattorini/ GlobalData As interest mounts in using RNA as a therapeutic